| IDEOGEN AG - Glassia 20 mg/ml, Infusionslösung |
| 68833 | | 01 | | Glassia 20 mg/ml | | Infusionslösung | | B02AB02 | | Alfa1-Antitrypsin | | 20.04.2023 | | |
|
| Composition |
| alpha-1-proteinasi inhibitor humanum 1000 mg, natrii dihydrogenophosphas dihydricus, natrii chloridum, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 50 ml, natrium 149.5-195.5 mg. |
| Packungsbestandteile |
| Solution pour perfusion | | | | | | | | Principe actif | Concentr. |
|---|
| Alpha-1-Proteinasi Inhibitor Humanum | 1000mg / 50ml |
| | BAG: Principe actif | Concentr. |
|---|
| Alpha-1-Proteinasi Inhibitor Humanum | 1000 mg |
| | | | Agents auxilliaires |
|---|
| Sodium Chlorure | | Sodium Dihydrogenophosphate Dihydrate | | Natrii Hydroxidum ad Ph |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | | 330.72 | 380.35 | B | LS | Non |
|
